Literature DB >> 18490012

Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis.

Lars Kocherscheidt1, Ann-Katrin Flakowski, Beate Grüner, David M Hamm, Klaus Dietz, Peter Kern, Peter T Soboslay.   

Abstract

The progressive growth of Echinococcus multilocularis metacestodes and their tissue infiltration will cause organ malfunction and finally failure. In few patients, E. multilocularis metacestode proliferation will spontaneously regress, but little is known about the determinants which may restrain metacestode survival and growth. In this study, chemokine responses were investigated in E. multilocularis patients at different states of infection, i.e. with progressive, stable and cured alveolar echinococcosis (AE). Characteristic chemokine profiles and changes in their production were observed in AE patients and infection-free controls when their peripheral blood cells were cultured with E. multilocularis antigens. The production of CC and CXC chemokines which associate with inflammation (MIP-1 alpha/CCL3, MIP-1 beta/CCL4, RANTES/CCL5 and GRO-alpha/CXCL1) was constitutively larger in AE patients than in controls; and the elevated chemokine releases were equal in patients with progressive, stable or cured AE. Cluster analyses identified three distinct chemokine response profiles; chemokines were enhanced, depressed or produced in similar quantities in AE patients and controls. A disparate cellular responsiveness was observed in AE patients to viable E. multilocularis vesicles; cluster 1 (GRO-alpha/CXCL1, MCP-3/CCL7, MCP-4/CCL13, TARC/CCL17, LARC/CCL20) and cluster 2 chemokines (PARC/CCL18, MDC/CCL22, MIG/CXCL9) were clearly diminished, while cluster 3 chemokines (MIP-1 alpha/CCL3, MIP-1 beta/CCL4, RANTES/CCL5) augmented. The increased production of inflammatory chemokines in patients even with cured AE could be induced by residual E. multilocularis metacestode lesions which continuously stimulate production of inflammatory chemokines. E. multilocularis metacestodes also suppressed cellular chemokine production in AE patients, and this may constitute an immune escape mechanism which reduces inflammatory host responses, prevents tissue destruction and organ damage, but may also facilitate parasite persistence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490012     DOI: 10.1016/j.exppara.2008.04.006

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  10 in total

1.  Tropical medicine at the University of Tübingen.

Authors:  Peter Gottfried Kremsner
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

3.  Transcriptional profiles of cytokine/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice.

Authors:  Junhua Wang; Renyong Lin; Wenbao Zhang; Liang Li; Bruno Gottstein; Oleg Blagosklonov; Guodong Lü; Chuangshan Zhang; Xiaomei Lu; Dominique A Vuitton; Hao Wen
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

Review 4.  Echinococcus metacestode: in search of viability markers.

Authors:  Bruno Gottstein; Junhua Wang; Oleg Blagosklonov; Frédéric Grenouillet; Laurence Millon; Dominique A Vuitton; Norbert Müller
Journal:  Parasite       Date:  2014-11-28       Impact factor: 3.000

5.  Fasciola hepatica Immune Regulates CD11c+ Cells by Interacting with the Macrophage Gal/GalNAc Lectin.

Authors:  Ernesto Rodríguez; Paula Carasi; Sofía Frigerio; Valeria da Costa; Sandra van Vliet; Verónica Noya; Natalie Brossard; Yvette van Kooyk; Juan J García-Vallejo; Teresa Freire
Journal:  Front Immunol       Date:  2017-03-15       Impact factor: 7.561

6.  Human cases of simultaneous echinococcosis and tuberculosis - significance and extent in China.

Authors:  Yu Rong Yang; Darren J Gray; Magda K Ellis; Shu Kun Yang; Philip S Craig; Donald P McManus
Journal:  Parasit Vectors       Date:  2009-11-04       Impact factor: 3.876

7.  Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients.

Authors:  Christian J Lechner; Beate Grüner; Xiangsheng Huang; Wolfgang H Hoffmann; Peter Kern; Peter T Soboslay
Journal:  Clin Dev Immunol       Date:  2012-08-30

8.  The Potential Role of Th9 Cell Related Cytokine and Transcription Factors in Patients with Hepatic Alveolar Echinococcosis.

Authors:  Tuerhongjiang Tuxun; Shadike Apaer; Hai-Zhang Ma; Heng Zhang; Amina Aierken; Ren-Yong Lin; Hao Wen
Journal:  J Immunol Res       Date:  2015-10-05       Impact factor: 4.818

9.  The correlations between Th1 and Th2 cytokines in human alveolar echinococcosis.

Authors:  Xiao Ma; Xuefei Zhang; Jia Liu; Yufang Liu; Cunzhe Zhao; Huixia Cai; Wen Lei; Junying Ma; Haining Fan; Jianye Zhou; Na Liu; Jingxiao Zhang; Yongshun Wang; Wei Wang; Peizhen Zhan; Xiongying Zhang; Qing Zhang; Kemei Shi; Peiyun Liu
Journal:  BMC Infect Dis       Date:  2020-06-15       Impact factor: 3.090

10.  Echinococcus multilocularis specific antibody, systemic cytokine, and chemokine levels, as well as antigen-specific cellular responses in patients with progressive, stable, and cured alveolar echinococcosis: A 10-year follow-up.

Authors:  Beate Grüner; Lynn Peters; Andreas Hillenbrand; Patrick Voßberg; Jonas Schweiker; Elisabeth G Rollmann; Laura H Rodriguez; Jasmin Blumhardt; Sanne Burkert; Peter Kern; Carsten Köhler; Peter T Soboslay
Journal:  PLoS Negl Trop Dis       Date:  2022-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.